A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging
- 17 January 2012
- Vol. 30 (4), 803-812
- https://doi.org/10.1016/j.vaccine.2011.10.093
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunityVaccine, 2008
- Current and future antiviral therapy of severe seasonal and avian influenzaAntiviral Research, 2008
- Human ImmunosenescenceAnnals of the New York Academy of Sciences, 2006
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Clinical Relevance of Age-Related Immune DysfunctionClinical Infectious Diseases, 2000
- Accumulation of somatic hypermutation and antigen-driven selection in rapidly cycling surface Ig+ germinal center (GC) B cells which occupy GC at a high frequency during the primary antihapten response in miceEuropean Journal of Immunology, 1997
- IgA class switch in I alpha exon-deficient mice. Role of germline transcription in class switch recombination.Journal of Clinical Investigation, 1996
- Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccineEuropean Journal of Immunology, 1992